Biogen Inc. EPS (Earnings per Share) 2007–2025
Biogen Inc. reported $8.79 of earnings per share for fiscal 2025. That was 21.4% lower than fiscal 2024. Compared with fiscal 2020, the change was -64.6%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $8.79 | -21.4% |
| FY 2024 | $11.18 | +40.3% |
| FY 2023 | $7.97 | -61.8% |
| FY 2022 | $20.87 | +100.7% |
| FY 2021 | $10.40 | -58.1% |
| FY 2020 | $24.80 | -21.1% |
| FY 2019 | $31.42 | +45.6% |
| FY 2018 | $21.58 | +81.0% |
| FY 2017 | $11.92 | -29.6% |
| FY 2016 | $16.93 | +10.4% |
| FY 2015 | $15.34 | +24.0% |
| FY 2014 | $12.37 | +58.4% |
| FY 2013 | $7.81 | +35.6% |
| FY 2012 | $5.76 | +14.3% |
| FY 2011 | $5.04 | +27.9% |
| FY 2010 | $3.94 | +17.6% |
| FY 2009 | $3.35 | +26.4% |
| FY 2008 | $2.65 | +33.2% |
| FY 2007 | $1.99 | — |
Source: Biogen Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BIIB 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Biogen Inc. reported $8.79 of earnings per share for fiscal 2025. That was 21.4% lower than fiscal 2024. Compared with fiscal 2020, the change was -64.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Biogen Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBiogen Inc. — frequently asked questions
What is Biogen Inc.'s earnings per share?
Biogen Inc. (BIIB) reported earnings per share of $8.79 for fiscal year 2025, per its SEC filings.
How has Biogen Inc.'s earnings per share changed over time?
Between fiscal 2007 and 2025, BIIB's earnings per share grew at roughly 8.6% per year (compound annual rate), from $1.99 to $8.79.
Where does this data come from?
Figures are computed from Biogen Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.